Diagnostics

Gene Solutions' SPOT-MAS 10 test gains FDA Breakthrough Designation, accelerating its path to the U.S. market and heralding a new era in early cancer detection.

Sysmex America's new XR-Series hematology analyzer promises to transform clinical labs with faster results, deeper insights, and a seamless workflow upgrade.

With the appointment of turnaround expert Lisa Nibauer as CEO, NOWDiagnostics signals a major push to commercialize its innovative at-home testing pipeline.

A new partnership aims to deploy AI-powered imaging and advanced training across Asia Pacific, tackling the region's leading cause of death head-on.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

Venture firm JVP leverages its strategic focus on vertical AI and cybersecurity, cashing in on four major portfolio exits in a landmark first quarter.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

Crossroads Counselling expands psychoeducational testing to age 30, addressing a critical gap in care amid long public waits and high academic pressures.

By partnering with BioBrasil to produce key diagnostic probes locally, Aliko Scientific is not just entering a market; it's rewriting the rules of play.

French biotech TreeFrog Therapeutics isn't just replacing cells; it's implanting pre-wired networks. Their novel 3D microtissue shows faster, more extensive brain repair.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

Dr. Craig Tendler's move to Predicta Biosciences signals a major shift, blending pharma expertise with biotech innovation to revolutionize cancer care.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Diagnostics Direct wins a Johns Hopkins award for a rapid test that detects active syphilis, promising same-day diagnosis and treatment to combat rising rates.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Lighten and Datavant have teamed up to turn messy medical notes into regulatory-grade data, aiming to dramatically speed up life sciences research.